-
Key Driver In The Betaferon Or Betaseron Global Market Report 2025:Rising Prevalence Of Multiple Sclerosis Drives Growth
22 Jan 2025 18:43 GMT
… include technological advancements, revolutionary drugs, digital health technologies, innovative … pharmaceutical and medical device sectors, partnered with Bayer to co-promote betaferon … , a multiple sclerosis MS treatment. This partnership …
-
Subcutaneous Biologics Market, Industry Trends And Global Forecasts To 2035: Subcutaneous Biologics Set To Transform Drug Delivery And Patient Adherence
16 Jan 2025 13:02 GMT
… offering targeted treatments with minimal drug interactions. … (Amgen) STELARA (Janssen Biotech) Trulicity (Eli Lilly) … Alteogen Foresee Pharmaceuticals SUBCUTANEOUS FORMULATION TECHNOLOGIES … BENLYSTA Betaseron / Betaferon / EXTAVIA CABLIVI …
-
Geopharm Healthcare to co-promote Bayer’s multiple sclerosis treatment
15 Oct 2024 07:11 GMT
… services for the multiple sclerosis treatment, Betaferon Injection (ingredient: interferon beta … distribution services in the pharmaceutical and medical device sectors.
"This … with domestic and international pharmaceutical companies, aiming to enhance …
-
Covid future variants can be restricted: Scientists on line of treatment
31 Aug 2022 11:28 GMT
… the four currently approved antiviral drugs with betaferon (interferon), which is a … class of antiviral drugs that protects from … are the approved antiviral drugs for COVID treatment. And the study suggests …
-
COVID-19 treatments for better protection against future variants identified
31 Aug 2022 10:55 GMT
… approved antiviral drugs with betaferon.
Betaferon is a class of antiviral drug that is … antiviral drugs, which can happen quickly and cause problems with treatment, also … are three approved antiviral drugs for the treatment of COVID-19: remdesivir …
-
Study reveals new COVID treatments, therapies and drug combinations
09 Aug 2022 12:47 GMT
… Professor Jindrich Cinatl (Institute of Medical Virology, Goethe-University).
Testing … antiviral drugs with Betaferon, an additional class of antiviral drug that … are three antiviral drugs approved for COVID treatment:
Remdesivir
Molnupiravir
Nirmatrelvir …
-
Researchers Help Future-Proof COVID-19 Treatments
08 Aug 2022 20:39 GMT
… Professor Jindrich Cinatl (Institute of Medical Virology, Goethe-University) tested the … the four currently approved antiviral drugs with betaferon – an additional class of … are three approved antiviral drugs for the treatment of COVID-19: remdesivir …
-
With 6.3% CAGR, Multiple Sclerosis Drugs Market Size Worth USD 41.99 Billion in 2028
26 Apr 2022 09:50 GMT
… pharmaceutical companies are conducting clinical trials … Drug Administration (FDA) has approved subcutaneous injection Kesimpta (ofatumumab), for the treatment … Betaferon … Drug Administration (FDA) approved drug name Ponvory in 2021, to treat MS. This medication …
-
Multiple Sclerosis Drugs Market Size Forecast [2022-2028] | is Projected to Reach USD 41.99 Billion, Exhibiting a CAGR of 6.3 %
19 Jan 2022 08:53 GMT
… many leading pharmaceutical companies are conducting clinical trials to discover … Drug Administration (FDA) has approved subcutaneous injection Kesimpta (ofatumumab), for the treatment … beta interferons such as Avonex, Betaferon, Extavia, Rebif. These steps …
-
Multiple Sclerosis Drugs Market to Reach USD 41.99 Billion by 2028 | Market Projection By Technology, Major key players, Growth, Revenue, CAGR, Regional Analysis, Industry Forecast To 2028
08 Nov 2021 08:56 GMT
… pharmaceutical companies are conducting clinical trials … such as Avonex, Betaferon, Extavia, Rebif. … excessive payments for medicines. Competitive Landscape … Drug Administration (FDA) has approved subcutaneous injection Kesimpta (ofatumumab), for the treatment …